NRXP logo

NRXPNRX Pharmaceuticals Inc

$3.97
$0.05
(1.28%)
Pre-Market
Updated: 04:48 AM EDT·Prev Close $3.92
Reported EarningsMay 15
Mkt Cap$157.71M
Vol2,637.00

About

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of NRX Pharmaceuticals Inc?
What is the 52-week high for NRX Pharmaceuticals Inc?
What is the 52-week low for NRX Pharmaceuticals Inc?
What is NRX Pharmaceuticals Inc stock price today?
What was NRX Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of NRX Pharmaceuticals Inc?
What is the Price-to-Book ratio of NRX Pharmaceuticals Inc?
What is the 50-day moving average of NRX Pharmaceuticals Inc?

Advertisement|Remove ads.